Enliven Therapeutics, Inc. (ELVN)
(Delayed Data from NSDQ)
$21.88 USD
-0.34 (-1.53%)
Updated Aug 30, 2024 03:59 PM ET
After-Market: $21.88 0.00 (0.00%) 7:58 PM ET
2-Buy of 5 2
C Value D Growth C Momentum D VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/14/24 |
---|---|
Current Quarter | -0.55 |
EPS Last Quarter | -0.41 |
Last EPS Surprise | 29.31% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -2.02 |
Next Year | -2.44 |
EPS (TTM) | -1.93 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | 0.50M |
# of Estimates | NA | NA | NA | 1 |
High Estimate | NA | NA | NA | 0.50M |
Low Estimate | NA | NA | NA | 0.50M |
Year ago Sales | 0.00M | 0.00M | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.55 | -0.57 | -2.02 | -2.44 |
# of Estimates | 2 | 2 | 2 | 2 |
Most Recent Consensus | -0.55 | -0.57 | -2.08 | -2.64 |
High Estimate | -0.55 | -0.57 | -1.95 | -2.23 |
Low Estimate | -0.55 | -0.57 | -2.08 | -2.64 |
Year ago EPS | -0.51 | -0.47 | -2.01 | -2.02 |
Year over Year Growth Est. | -7.84% | -21.28% | -0.50% | -20.79% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 2 | 2 | 2 | 2 |
Up Last 60 Days | 2 | 2 | 2 | 2 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.55 | -0.57 | -2.02 | -2.44 |
7 Days Ago | -0.55 | -0.57 | -2.02 | -2.44 |
30 Days Ago | -0.62 | -0.64 | -2.26 | -2.74 |
60 Days Ago | -0.62 | -0.64 | -2.26 | -2.74 |
90 Days Ago | -0.62 | -0.64 | -2.26 | -2.74 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.55 | -0.57 | -2.02 | -2.44 |
Zacks Consensus Estimate | -0.55 | -0.57 | -2.02 | -2.44 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.41 | -0.54 | -0.47 | -0.51 | NA |
Estimate | -0.58 | -0.58 | -0.56 | -0.49 | NA |
Difference | 0.17 | 0.04 | 0.09 | -0.02 | 0.07 |
Surprise | 29.31% | 6.90% | 16.07% | -4.08% | 12.05% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more